In this article, the $q$-analogues of the linear relations of non-strict multiple zeta values called "the sum formula" and "the cyclic sum formula" are established.
Abstract Among the various histopathological patterns of drug-induced interstitial lung disease (DILD), diffuse alveolar damage (DAD) is associated with poor prognosis. However, there is no reliable biomarker for its accurate diagnosis. Here, we show stratifin/14-3-3σ (SFN) as a biomarker candidate found in a proteomic analysis. The study included two independent cohorts and controls ( n = 432 samples). SFN was specifically elevated in DILD patients with DAD, and was superior to the known biomarkers, KL-6 and SP-D, in discrimination of DILD patients with DAD from patients with other DILD patterns or other lung diseases, including bacterial pneumonia. SFN was also increased in serum from patients with idiopathic DAD, and in lung tissues and bronchoalveolar lavage fluid of patients with DAD. In vitro analysis using the A549 cell line suggested that extracellular release of SFN occurred via p53 activation. We conclude that serum SFN is a promising biomarker for DAD diagnosis.
Coronary thrombolysis or percutaneous transluminal coronary recanalization (PTCR) has recently been established as a treatment of acute myocardial infarction (AMI). This study was performed to elucidate the changes in plasma levels of β-thromboglobulin (β-TG), fibrinopeptides and prostaglandins before and after the PTCR. Twenty-six AMI patients within 6 hours after its onset, 53±12.1 (SD) years of age were subjected for the PTCR using with urokinase (680, 000±124, 000 IU). Eleven patients among 26 undergone PTCR were selected for the determination of plasma levels of β-TG, thromboxane B2 (TXB2), 6-keto-PGF1α, fibrinopeptide A (FpA) and FpBβ 15-42 before and serially after PTCR.Successful recanalization was obtained in 18 out of 26 cases (69.2%). β-TG was elevated both in successful and unsuccessful cases suggesting platelet activation in AMI. Those who achieved good recanalization demonstrated a sharp rise of β-TG probably due to wash-out phenomenon shortly after the recanalization. β-TG returned to the normal range within 1-7 days (Fig. 1) TXB2 was increased in both groups, higher in the recanalized group and gradually returned to the normal range in several days. Two out of 5 recanalized cases demonstrated wash-out phenomenon. 6-keto-PGF1α levels were also increased in AMI which became normalized in a day. FpA was increased in both groups in the acute stage of AMI suggesting the hypercoagulable state and gradually decreased to the normal range. FpBβ made a peak at the termination of PTCR, higher in the recanalized cases suggesting better fibrinolysis, and rapidly decreased in a day. A typical case of successful PTCR was shown in Figure 2. Marked rises in β-TG and TXB2 shortly after PTCR may indicate recanalization of the obstructed coronary artery.
For any integer $k$, M.Kaneko defined $k$-th poly-Bernoulli numbers as a kind of generalization of classical Bernoulli numbers using $k$-th polylogarithm. In case when $k$ is positive, $k$-th poly-Bernoulli numbers is a sequence of rational numbers as same as classical Bernoulli numbers. On the other hand, in case when $k$ is negative, it is a sequence of positive integers, and many combinatoric and number theoretic properties has been investigated. In the present paper, the negative case is treated, and their congruence and $p$-adic properties are discussed. Beside of them, application of the results to obtain a congruence property for the number of lonesum matrices is also mentioned.
Poly-Euler numbers are introduced in [9] via special values of an L-function as a generalization of the Euler numbers. In this article, poly-Euler numbers with negative index are mainly treated, and the parity of them is shown as the main theorem. Furthermore the divisibility of poly-Euler numbers are also discussed. x1. Introduction
A duality-type relation for height one multiple zeta-star values is established. A conjectural generalization to the case of arbitrary height is also presented.
Abstract Drug-induced interstitial lung disease (DILD) occurs when drug exposure causes inflammation of the lung interstitium. DILD can be caused by different types of drugs, and some DILD patterns results in a high mortality rate; hence, DILD poses a serious problem in clinical practice as well as drug development, and strategies to diagnose and distinguish DILD from other lung diseases are necessary. We aimed to identify novel biomarkers for DILD by performing lipidomics analysis on plasma samples from patients with acute and recovery phase DILD. Having identified lysophosphatidylcholines (LPCs) as candidate biomarkers for DILD, we determined their concentrations using validated liquid chromatography/mass spectrometry biomarker assays. In addition, we evaluated the ability of LPCs to discriminate patients with acute phase DILD from those with recovery phase DILD, DILD-tolerant, or other lung diseases, and characterized their association with clinical characteristics. Lipidomics analysis revealed a clear decrease in LPC concentrations in the plasma of patients with acute phase DILD. In particular, LPC(14:0) had the highest discriminative index against recovery phase and DILD-tolerant patients. LPC(14:0) displayed no clear association with causal drugs, or subjects’ backgrounds, but was associated with disease severity. Furthermore, LPC(14:0) was able to discriminate between patients with DILD and other lung diseases, including idiopathic interstitial pneumonia and lung disease associated with connective tissue disease. LPC(14:0) is a promising biomarker for DILD that could improve the diagnosis of DILD and help to differentiate DILD from other lung diseases, such as idiopathic interstitial pneumonia and connective tissue disease.